Get 50% OFF This Monsoon!
Aprameya Engineering
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Aprameya Engineering Ltd was originally formed as a partnership firm in the name and style of 'M/s. Aprameya Engineering' pursuant to a Deed of Partnership dated September 05, 2003, registered as on August 13, 2004 at Ahmedabad under the Indian Partnership Act, 1932. Subsequently, Company incorporated pursuant to a Certificate of Incorporation dated December 28, 2021 issued by the Registrar of Companies, following the conversion of Partnership Firm 'M/s. Aprameya Engineering' to a Private Limited Company. Further, pursuant to Special Resolution on April 22, 2022, Company converted into a Public Limited Company and consequently its name was changed from 'Aprameya Engineering Private Limited' to 'Aprameya Engineering Limited' vide a fresh Certificate of Incorporation consequent upon conversion dated May 12, 2022, issued by the Registrar of Companies, Ahmedabad.
The Company is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre (OT) and prefabricated structure ward in the hospitals and medical care centres on turnkey basis along with supply of high value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals and medical practitioners. Their portfolio in products and services can be classified into two different segments i.e. setting up of healthcare infrastructure within the hospitals and medical care centres and dealing in high value medical equipment.
The Company provide need based medical equipment to hospitals, medical practitioners, and diagnostic service providers, including patient monitoring systems, cardiology devices, respiratory management systems and radiology/ imaging systems. Some of the major critical care products as supplied by them include Harmonic ultrasonic surgical instruments, patient monitoring systems, ventilator (NIV), ABG machine, integrated electro-surgical units and anesthesia delivery systems etc.
The medical and healthcare infrastructure solution of the Company include designing & installation of modular & prefabricated operation theatre & ICU, operating rooms & intensive care pendants, LED operating lights & OT tables, high care hospital beds, setting up of medical gas pipeline solutions, high value equipment like ventilators, multipara patient monitoring system, critical care equipment, diagnostic equipment, CSSD equipment and setting up of mini laboratories within the ICUs.
The Company started the business as a Partnership Firm on September 05, 2003 and grew the business with delivering healthcare solutions focused on cost effectiveness and improved accessibility.
In 2004, the Firm signed a distributorship agreement with Johnson & Johnson Private Limited. It signed an agreement with Alan Electronic System Private Limited for completing the Market of ELSY 360 series Diathermy Equipment being manufactured by them.
In 2009, it signed an agreement with Karl Storz Endoscopy India Private Limited for supplying of medical equipment to the Rajasthan Government.
In 2020, they expanded business activity by providing turnkey healthcare infrastructure solution by setting-up of Intensive Care Units (ICUs), Neonatal Intensive Care Units (NICUs), Pediatric Intensive Care Units (PICUs) and Operation Theatre (OT) projects and prefabricated structure ward on turnkey basis. It started the business of setting up of ICUs and operation theatres in 2020, and have since then completed the installation of around 1181 critical care beds including ICUs, NICUs, PICUs and modular operation theatre across the state of Rajasthan amounting to over Rs 12,000 Lakhs.
In 2022, the Company enhanced capabilities and started work related to installation and setting up of Minilabs for ICU/OT/PICU/NICU.
Currently, the Company is working on 11 projects for different government and private hospitals namely Government Medical College & Hospital Dungarpur (Rajasthan), RNT Medical College & Controller (Associated Group of Hospitals, Udaipur, (Raj.), SMS Medical College, Jaipur, Government Medical College & Controller A.G. of Hospital, Kota, Government Medical College, Pali, Barmer, Jhalawar and DR. S N Medical College, Jodhpur, MGH Hospital.
The Company is planning to raise capital from Public by issuing 50,00,000 Equity Shares through Fresh Issue.
Aprameya Engineering share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Aprameya Engineering indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Aprameya Engineering is valued compared to its competitors.
Aprameya Engineering PE ratio helps investors understand what is the market value of each stock compared to Aprameya Engineering 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Aprameya Engineering evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Aprameya Engineering generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Aprameya Engineering in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Aprameya Engineering shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Aprameya Engineering compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Aprameya Engineering over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Aprameya Engineering helps investors get an insight into when they can enter or exit the stock. Key components of Aprameya Engineering Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Aprameya Engineering shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Aprameya Engineering ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Aprameya Engineering provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Aprameya Engineering highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Aprameya Engineering .
The balance sheet presents a snapshot of Aprameya Engineering ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App